Paid Clinical Trials in Los Angeles, CA

Browse 100 Paid Studies Los Angeles Across 801 Cities
42 Phase 3 Trial · 3865 Paid Studies Los Angeles Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Paid Clinical Trials in Los Angeles, CA

Reviewed by Michael Gill, B. Sc.

Image of Juravinski Cancer Center in Hamilton, Canada.

10 Paid Studies Los Angeles Near Me

Top Cities for Paid Studies Los Angeles

Los Angeles

156Active Trials

Cedars Sinai Medical CenterTop Active Site

New York

91Active Trials

Memorial Sloan Kettering Cancer CenterTop Active Site

Paid Studies Los Angeles by Phase of Trial

N/A Paid Studies Los Angeles

16Active Paid Studies Los Angeles

16Number of Unique Treatments

601Number of Active Locations

Portico transcatheter aortic valve Transcatheter Tricuspid Valve Replacement ACURATE neo2™ Transfemoral TAVR System WATCHMAN FLX LAAC Device Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)Study Treatment Telemetric Intervention Proud & Empowered WATS3D brushings, then Seattle Protocol.Care2Sleep Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System Infuse™ Bone Graft (Infuse™)Bilateral Salpingectomy My Future Self Intervention Treatment Optune®

Most Recent Paid Studies Los Angeles

Clinical Trial

Began Recruiting Date

Phase

Osimertinib for Lung Cancer

9/15/2023

Phase 1

Study G Risankizumab for Psoriasis

8/10/2023

Phase 4

2.5 mg LTI-03 BID for Idiopathic Pulmonary Fibrosis

7/6/2023

Phase 1

Phase 2: Cemiplimab for Non-Small Cell Lung Cancer

4/21/2023

Phase 2

Phase 1A: ELI-002 7P (Low Peptide dose) for Colorectal Cancer

4/14/2023

Phase 1 & 2

About The Author

Michael Gill - B. Sc.

First Published: October 29th, 2021

Last Reviewed: September 2nd, 2023

References¹ Mellon L, Doyle F, Hickey A, Ward KD, de Freitas DG, McCormick PA, O'Connell O, Conlon P. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients. Cochrane Database Syst Rev. 2022 Sep 12;9:CD012854. doi: 10.1002/14651858.CD012854.pub2. Review. https://pubmed.ncbi.nlm.nih.gov/36094829² Mellon L, Doyle F, Hickey A, Ward KD, de Freitas DG, McCormick PA, O'Connell O, Conlon P. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients. Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2. https://pubmed.ncbi.nlm.nih.gov/36094829³ Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Søndergaard L. Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med. 2015 Nov 19;373(21):2015-24. doi: 10.1056/NEJMoa1509233. Epub 2015 Oct 5. https://pubmed.ncbi.nlm.nih.gov/26436963⁴ Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, Carrum G, Sasa G, Lulla P, Watanabe A, Kuvalekar M, Gee AP, Wu MF, Liu H, Grilley BJ, Krance RA, Gottschalk S, Brenner MK, Rooney CM, Heslop HE, Leen AM, Omer B. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2017 Nov 1;35(31):3547-3557. doi: 10.1200/JCO.2017.73.0655. Epub 2017 Aug 7. https://pubmed.ncbi.nlm.nih.gov/28783452⁵ Dossier C, Hogan J. Response to Majeranowski. Pediatr Nephrol. 2021 Jun;36(6):1653. doi: 10.1007/s00467-021-04982-4. Epub 2021 Mar 10. https://pubmed.ncbi.nlm.nih.gov/33693991⁶ Dossier C, Hogan J. Response to Majeranowski. Pediatr Nephrol. 2021 Jun;36(6):1653. doi: 10.1007/s00467-021-04982-4. Epub 2021 Mar 10. No abstract available. https://pubmed.ncbi.nlm.nih.gov/33693991⁷ Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuss G. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC Heart Fail. 2018 Oct;6(10):874-883. doi: 10.1016/j.jchf.2018.04.010. Epub 2018 May 10. Erratum In: JACC Heart Fail. 2023 Jan;11(1):132. https://pubmed.ncbi.nlm.nih.gov/29754812⁸ Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuß G. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC Heart Fail. 2018 Oct;6(10):874-883. doi: 10.1016/j.jchf.2018.04.010. Epub 2018 May 10. https://pubmed.ncbi.nlm.nih.gov/29754812⁹ Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuss G. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. JACC Heart Fail. 2018 Oct;6(10):874-883. doi: 10.1016/j.jchf.2018.04.010. Epub 2018 May 10. https://pubmed.ncbi.nlm.nih.gov/29754812¹⁰ Kuusk T, Abu-Ghanem Y, Mumtaz F, Powles T, Bex A. Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapy. Curr Opin Urol. 2021 May 1;31(3):262-269. doi: 10.1097/MOU.0000000000000868. Review. https://pubmed.ncbi.nlm.nih.gov/33742979